3 GI Case Quizzes: Cirrhosis-related Bleeding

Your daily dose of the clinical news you may have missed.

Recurrent C difficile requires pulse vancomycin therapy; fecal microbiota transplant shows promise.

More participants consuming either of 2 common IBS dietary regimens experienced significant and sustained symptom relief vs those given pharmacotherapy.

The goals of therapy for patients with inflammatory bowel disorder include inducing and maintaining a steroid-free remission, preventing and treating the complications of the disease, minimizing treatment toxicity, achieving mucosal healing, and enhancing quality of life.

Submission based on results from the phase 3 QUASAR induction study, which showed statistically significant and clinically meaningful improvements in symptoms.

Your daily dose of the clinical news you may have missed.